2000
DOI: 10.1080/088800100276550
|View full text |Cite
|
Sign up to set email alerts
|

Immune Thrombocytopenia and Hemolytic Anemia as a Presenting Manifestation of Hodgkin Disease

Abstract: h A very unusual clinical presentation of Hodgkin disease with immune thrombocytopeni a and autoimmune hemolytic anemia is reported. A 6.5-year-old boy presented with thrombocytopenia, Coombs' positive hemolytic anemia, and multiple small posterior cervical lymph nodes. After a course of high-dose methylprednisolon e therapy with a diagnosis of Evans syndrome, complete response for thrombocytopenia and partial response for anemia was achieved. Six weeks later there was a sudden increase in the size of left pos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

2001
2001
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 9 publications
2
21
0
Order By: Relevance
“…The recent Consensus Recommendations of IAPCOI [1] has recommended the 0-6wks-6months schedule, the first dose to be administered at birth, second dose at 6 weeks and third dose at 6 months. The reason being it is more closer to immunologically ideal and most widely used 0-1-6 months schedule, and also conforms to latest ACIP recommendations wherein the final dose in the Hepatitis-B vaccine series should be administered no earlier than 24 weeks and at least 16 weeks after the first dose [2] . Therefore, the question arises as to the rationality of…”
Section: Hepatitis B Vaccinationmentioning
confidence: 69%
See 1 more Smart Citation
“…The recent Consensus Recommendations of IAPCOI [1] has recommended the 0-6wks-6months schedule, the first dose to be administered at birth, second dose at 6 weeks and third dose at 6 months. The reason being it is more closer to immunologically ideal and most widely used 0-1-6 months schedule, and also conforms to latest ACIP recommendations wherein the final dose in the Hepatitis-B vaccine series should be administered no earlier than 24 weeks and at least 16 weeks after the first dose [2] . Therefore, the question arises as to the rationality of…”
Section: Hepatitis B Vaccinationmentioning
confidence: 69%
“…Hematologic malignancies such as Hodgkins lymphoma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia have been associated with immune thrombocytopenic purpura (ITP) but it is rare to see ITP in patient with acute lymphoblastic leukemia (ALL) [1,2]. ALL is a immunosuppressive disease and chemotherapy results in further immunosuppressive state.…”
mentioning
confidence: 99%
“…Untreated ALL is usually fatal within 6 months, but with the best therapy 70-80% of children and 20-30% of adults survive beyond 5 years [13]. Acute leukemia in remission followed by ITP was not found in the course of our literature even though, found documented are many ITP associated disorders [14,15] involving lymphocyte abnormalities like large granular lymphocyte syndrome, lymphoproliferative disorders like Chronic Lymphocytic Leukemia (CLL) and lymphomas, others include autoimmune lymphoproliferative disorders, autoimmune haemolytic anaemias, Systemic Lupus Erythematosus (SLE) and antiphospholipid syndrome; direct link of ALL with ITP is yet to be reported in literature. The closest reported was AML masquerading as ITP [6].…”
Section: Discussionmentioning
confidence: 68%
“…Immune thrombocytopenia (ITP) is frequently associated with HD as well [7, 8]. However, combined AIHA and ITP (Evans syndrome) has rarely been reported in association with HD [4, 9, 10, 11]. We report here a case of HD associated with DAT-negative Evans syndrome and discuss the significance of the measurement of RBC-IgG in cases of HD with anaemia.…”
Section: Introductionmentioning
confidence: 98%